Showing session: reset
Harnessing Breakthroughs, Targeting Cures
- Sort by:
- Browse by:
- Free
- podium video
- slides video
- audio + slides
- All slides included
Transcriptional and epigenetic control of tumor cells
Richard A. Young
MIT Whitehead Inst. for Biomed. Research, Cambridge, MA, United States
- Free
- Coming soon
- Some slides withheld
The two faces of p53: Tumor suppressor and oncogene
Carol L. Prives
Columbia Univ., New York, NY, United States
- Free
- podium video
- slides video
- audio + slides
- All slides included
Final results of a randomized Phase II study of PD 0332991, a cyclin-dependent kinase (CDK)-4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1; TRIO-18)
Richard S. Finn
UCLA, Los Angeles, CA, United States
- Free
- podium video
- slides video
- audio + slides
- All slides included
Discussant
José Baselga
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
- Free
- podium video
- audio + slides
- Some slides withheld
New lymphoma therapies based on functional and structural genomics
Louis M. Staudt
NCI-CCR, Bethesda, MD, United States
- Free
- podium video
- slides video
- audio + slides
- All slides included
Diet and cancer: Status report in 2014
Walter C. Willett
Harvard School of Public Health, Boston, MA, United States
- Free
- podium video
- slides video
- audio + slides
- All slides included
Tumor-specific immune activation: Immuno-oncology comes of age
Roger M. Perlmutter
Merck Research Laboratories, Rahway., NJ, United States